Search results
Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend...
Simply Wall St. via Yahoo Finance· 2 months agoExelixis' (NASDAQ:EXEL) stock is up by a considerable 16% over the past month. However, we decided...
Exelixis, Inc. (NASDAQ:EXEL) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear...
Simply Wall St. via Yahoo Finance· 8 months agoExelixis (NASDAQ:EXEL) has had a great run on the share market with its stock up by a significant...
Exelixis, Inc.'s (NASDAQ:EXEL) Stock Has Shown Weakness Lately But Financial Prospects Look Decent:...
Simply Wall St. via Yahoo Finance· 2 years agoWith its stock down 24% over the past three months, it is easy to disregard Exelixis (NASDAQ:EXEL)....
Exelixis, Inc. (NASDAQ:EXEL) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 months agoExelixis, Inc. (NASDAQ:EXEL) Q2 2023 Earnings Call Transcript August 1, 2023 Exelixis, Inc. beats...
Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the...
Simply Wall St. via Yahoo Finance· 4 weeks agoKey Insights Significantly high institutional ownership implies Exelixis' stock price is sensitive...
With 79% ownership of the shares, Exelixis, Inc. (NASDAQ:EXEL) is heavily dominated by institutional...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Given the large stake in the stock by institutions, Exelixis' stock price might be...
Exelixis (EXEL) Q2 Earnings Top, Cabometyx Drives Growth
Zacks via Yahoo Finance· 9 months agoExelixis, Inc. EXEL reported earnings of 31 cents per share in the first quarter of 2023, which...
Exelixis Inc (EXEL) Reports Q3 2023 Earnings: Total Revenues of $471.9 Million
GuruFocus.com via Yahoo Finance· 6 months agoExelixis Inc (NASDAQ:EXEL) reported total revenues of $471.9 million for Q3 2023, compared to $411.7...
Why Is Exelixis (EXEL) Down 0.6% Since Last Earnings Report?
Zacks via Yahoo Finance· 11 months agoIt has been about a month since the last earnings report for Exelixis (EXEL). Shares have lost about...
Exelixis (EXEL) Reports Positive EU Patent Ruling for Cabometyx
Zacks via Yahoo Finance· 4 months agoExelixis, Inc. EXEL announced that it has successfully defended an EU patent for Cabometyx...